Goosehead (GSHD) director awarded 13,979 options vesting over three years

Rhea-AI Filing Summary

Goosehead Insurance, Inc. director Peter R. Lane received a grant of 13,979 Director Stock Options linked to Class A Common Stock. The options have an exercise price of $42.46 per share and expire on May 5, 2036.

The options vest in 12 equal quarterly installments over three years following the grant date, subject to Lane’s continued service. All unvested options will fully vest and become exercisable if a defined change in control occurs. Following this grant, Lane holds 13,979 options directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Lane Peter R.

Role null

Type	Security	Shares	Price	Value
Grant/Award	Director Stock Options (right to buy)	13,979	$0.00	--

Holdings After Transaction: Director Stock Options (right to buy) — 13,979 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Options granted: 13,979 options Exercise price: $42.46 per share Expiration date: May 5, 2036 +3 more

6 metrics

Options granted 13,979 options Director stock options granted on May 5, 2026

Exercise price $42.46 per share Strike price for director stock options

Expiration date May 5, 2036 Option term under Omnibus Incentive Plan

Vesting schedule 12 quarterly installments Over three years following grant date

Underlying shares 13,979 Class A shares Underlying Goosehead Class A Common Stock

Post-grant derivative holdings 13,979 options Total options held following this transaction

Key Terms

Director Stock Options, vest and become exercisable, change in control, Omnibus Incentive Plan, +1 more

5 terms

Director Stock Options financial

"security_title": "Director Stock Options (right to buy)"

vest and become exercisable financial

"The shares subject to the option shall vest and become exercisable"

change in control financial

"will vest and become exercisable upon a "change in control""

A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.

Omnibus Incentive Plan financial

"as defined in the Issuer's Amended and Restated Omnibus Incentive Plan"

An omnibus incentive plan is a single, flexible program a company uses to give employees and executives different types of pay tied to performance — for example stock options, restricted shares, cash bonuses and other awards — all governed by one set of rules. It matters to investors because it determines how many new shares may be created, how leaders are motivated and how much the company will spend on compensation over time; think of it as a master toolbox that affects both costs and the total share supply.

exercise price financial

"conversion_or_exercise_price": "42.4600""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lane Peter R.

(Last) (First) (Middle)

C/O GOOSEHEAD INSURANCE, INC.

1500 SOLANA BLVD., BLDG 4, STE 4500

(Street)

WESTLAKE TEXAS 76262

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Goosehead Insurance, Inc. [ GSHD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Director Stock Options (right to buy)	$42.46	05/05/2026		A		13,979		(1)	05/05/2036	Class A Common Stock	13,979	$0	13,979	D

Explanation of Responses:

1. The shares subject to the option shall vest and become exercisable, subject to continued service, in 12 equal quarterly installments over the three (3) year period following the grant date; provided that all shares subject to the option will vest and become exercisable upon a "change in control" (as defined in the Issuer's Amended and Restated Omnibus Incentive Plan).

Remarks:

	/s/ Martin Thornthwaite, as Attorney-in-Fact for Peter R. Lane	05/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Goosehead Insurance (GSHD) report in this Form 4 filing?

Goosehead Insurance reported that director Peter R. Lane received a grant of 13,979 director stock options. These options relate to Class A Common Stock and were awarded as compensation, not purchased in the open market, and are subject to multi-year vesting conditions.

How many stock options did Goosehead director Peter R. Lane receive?

Peter R. Lane received 13,979 director stock options in this transaction. All 13,979 options are held directly after the grant, providing the right to acquire an equal number of Goosehead Insurance Class A Common shares if the options vest and are exercised.

What are the vesting terms of Peter R. Lane’s Goosehead (GSHD) options?

The options vest in 12 equal quarterly installments over three years following the grant date. Vesting requires Lane’s continued service with the company, and any unvested installments could be forfeited if service ends before fully satisfying the vesting schedule.

What is the exercise price and expiration date of the Goosehead options granted?

The director stock options carry an exercise price of $42.46 per share and expire on May 5, 2036. Lane may exercise vested options at that price any time before expiration, subject to the company’s plan rules and any applicable trading or blackout restrictions.

When do the Goosehead (GSHD) options fully vest in the event of a change in control?

All unvested options will fully vest and become exercisable upon a qualifying change in control. The term “change in control” is defined in Goosehead Insurance’s Amended and Restated Omnibus Incentive Plan, and accelerated vesting applies if such an event occurs while the grant is outstanding.